Skip to main content
Clinical Trials/ACTRN12622001368729
ACTRN12622001368729
Not yet recruiting
未知

Virtual reality immersion therapy for symptom management in Palliative Care inpatients: feasibility trial.

Visor Immersive0 sites70 target enrollmentOctober 25, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Terminal illness
Sponsor
Visor Immersive
Enrollment
70
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 25, 2022
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Visor Immersive

Eligibility Criteria

Inclusion Criteria

  • adult patient requiring treatment as palliative care in\-patient
  • \- alert and orientated
  • \- expected to stay in hospital for more than 48 hours.

Exclusion Criteria

  • \- one or more episodes of delirium during this hospitalisation
  • \- non\-English speaking
  • \- contra\-indications to using VR device: severe vertigo, seizures, monocular vision, simulation sickness.

Outcomes

Primary Outcomes

Not specified

Similar Trials